Steatosis News and Research

RSS
Targeted molecular therapy reduces initial development of NAFLD in mice

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers develop in vitro model system for investigating etiology of NAFLD

Researchers develop in vitro model system for investigating etiology of NAFLD

Pioglitazone effective in diabetes patients with NASH

Pioglitazone effective in diabetes patients with NASH

NR supplements can reduce diabetes-related complications in mice

NR supplements can reduce diabetes-related complications in mice

Daily dose of coffee could help reverse non-alcoholic fatty liver disease

Daily dose of coffee could help reverse non-alcoholic fatty liver disease

Newcastle scientists develop new type of genetic blood test to diagnose liver scarring

Newcastle scientists develop new type of genetic blood test to diagnose liver scarring

Researchers find prevalence of steatosis in liver transplant recipients

Researchers find prevalence of steatosis in liver transplant recipients

Absence of PEMT enzyme leads to development of fatty liver disease and tumours in thin patients

Absence of PEMT enzyme leads to development of fatty liver disease and tumours in thin patients

Potential treatment target identified for fatty liver disease

Potential treatment target identified for fatty liver disease

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

Georgia State University researcher receives $1.35 million federal grant to study effects of emulsifiers

Georgia State University researcher receives $1.35 million federal grant to study effects of emulsifiers

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

NuSI launches groundbreaking clinical study to halt nonalcoholic fatty liver disease in children

NuSI launches groundbreaking clinical study to halt nonalcoholic fatty liver disease in children

Study shows NASH linked to 50% higher death rates compared with NAFLD

Study shows NASH linked to 50% higher death rates compared with NAFLD

Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD

Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Scientists develop computer model to predict how liver stores fat

Scientists develop computer model to predict how liver stores fat

Exposure to hormone-disrupting chemicals can cause fatty liver disease, promote obesity

Exposure to hormone-disrupting chemicals can cause fatty liver disease, promote obesity

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Component of Glycyrrhiza uralensis plant may thwart development of metabolic disorders

Component of Glycyrrhiza uralensis plant may thwart development of metabolic disorders